【市場調査レポート】鉄欠乏性貧血治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Iron Deficiency Anemia Treatment Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。鉄欠乏性貧血治療のグローバル市場インサイト・予測（～2028年） / Global Iron Deficiency Anemia Treatment Market Insights, Forecast to 2028 / QY2207E09239資料のイメージです。

• レポートコード：QY2207E09239
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の鉄欠乏性貧血治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に鉄欠乏性貧血治療の世界市場のxxx％を占める「硫酸第一鉄」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の鉄欠乏性貧血治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの鉄欠乏性貧血治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの鉄欠乏性貧血治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

鉄欠乏性貧血治療のグローバル主要メーカーには、AdvaCare Pharma、Akorn、Sun Pharmaceutical Industries Ltd.、Akebia Therapeutics, Inc.、Rockwell Medical, Inc.、Vifor Pharma Management Ltd.、Shield Therapeutics、AMAG Pharmaceuticals、Pharmacosmos A/Sなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

鉄欠乏性貧血治療市場は、種類と用途によって区分されます。世界の鉄欠乏性貧血治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他

【用途別セグメント】
病院薬局、小売薬局、オンライン薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 鉄欠乏性貧血治療製品概要
- 種類別市場（硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他）
- 用途別市場（病院薬局、小売薬局、オンライン薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の鉄欠乏性貧血治療販売量予測2017-2028
- 世界の鉄欠乏性貧血治療売上予測2017-2028
- 鉄欠乏性貧血治療の地域別販売量
- 鉄欠乏性貧血治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別鉄欠乏性貧血治療販売量
- 主要メーカー別鉄欠乏性貧血治療売上
- 主要メーカー別鉄欠乏性貧血治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他）
- 鉄欠乏性貧血治療の種類別販売量
- 鉄欠乏性貧血治療の種類別売上
- 鉄欠乏性貧血治療の種類別価格
・用途別市場規模（病院薬局、小売薬局、オンライン薬局）
- 鉄欠乏性貧血治療の用途別販売量
- 鉄欠乏性貧血治療の用途別売上
- 鉄欠乏性貧血治療の用途別価格
・北米市場
- 北米の鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（トルコ、サウジアラビア）
・企業情報
AdvaCare Pharma、Akorn、Sun Pharmaceutical Industries Ltd.、Akebia Therapeutics, Inc.、Rockwell Medical, Inc.、Vifor Pharma Management Ltd.、Shield Therapeutics、AMAG Pharmaceuticals、Pharmacosmos A/S
・産業チェーン及び販売チャネル分析
- 鉄欠乏性貧血治療の産業チェーン分析
- 鉄欠乏性貧血治療の原材料
- 鉄欠乏性貧血治療の生産プロセス
- 鉄欠乏性貧血治療の販売及びマーケティング
- 鉄欠乏性貧血治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 鉄欠乏性貧血治療の産業動向
- 鉄欠乏性貧血治療のマーケットドライバー
- 鉄欠乏性貧血治療の課題
- 鉄欠乏性貧血治療の阻害要因
・主な調査結果

People with iron deficiency and mild to moderate anemia are mainly treated with oral iron, and their diets should be improved to eat iron-rich foods. Severe anemia can be treated with oral iron or intravenous iron, as well as a small number of repeated infusions of packed red blood cells. However, intravenous iron supplementation is not recommended during the first trimester.
Market Analysis and Insights: Global Iron Deficiency Anemia Treatment Market
Due to the COVID-19 pandemic, the global Iron Deficiency Anemia Treatment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Ferrous Sulfate accounting for % of the Iron Deficiency Anemia Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Iron Deficiency Anemia Treatment market size is valued at US$ million in 2021, while the US and Europe Iron Deficiency Anemia Treatment are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Iron Deficiency Anemia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Iron Deficiency Anemia Treatment include AdvaCare Pharma, Akorn, Sun Pharmaceutical Industries Ltd., Akebia Therapeutics, Inc., Rockwell Medical, Inc., Vifor Pharma Management Ltd., Shield Therapeutics, AMAG Pharmaceuticals and Pharmacosmos A/S. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Iron Deficiency Anemia Treatment Scope and Segment
Iron Deficiency Anemia Treatment market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Iron Deficiency Anemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Ferrous Sulfate
Ferrous Gluconate
Ferrous Fumerate
Ferric Hydroxide
Sodium Ferric Gluconate
Iron Carbohydrates
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Company
AdvaCare Pharma
Akorn
Sun Pharmaceutical Industries Ltd.
Akebia Therapeutics, Inc.
Rockwell Medical, Inc.
Vifor Pharma Management Ltd.
Shield Therapeutics
AMAG Pharmaceuticals
Pharmacosmos A/S
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Iron Deficiency Anemia Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Iron Deficiency Anemia Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ferrous Sulfate
1.2.3 Ferrous Gluconate
1.2.4 Ferrous Fumerate
1.2.5 Ferric Hydroxide
1.2.6 Sodium Ferric Gluconate
1.2.7 Iron Carbohydrates
1.2.8 Others
1.3 Market by Application
1.3.1 Global Iron Deficiency Anemia Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Iron Deficiency Anemia Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Iron Deficiency Anemia Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Iron Deficiency Anemia Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Iron Deficiency Anemia Treatment Sales by Region
2.4.1 Global Iron Deficiency Anemia Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Iron Deficiency Anemia Treatment by Region (2023-2028)
2.5 Global Iron Deficiency Anemia Treatment Revenue by Region
2.5.1 Global Iron Deficiency Anemia Treatment Revenue by Region (2017-2022)
2.5.2 Global Iron Deficiency Anemia Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Iron Deficiency Anemia Treatment Sales by Manufacturers
3.1.1 Global Top Iron Deficiency Anemia Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Iron Deficiency Anemia Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Iron Deficiency Anemia Treatment in 2021
3.2 Global Iron Deficiency Anemia Treatment Revenue by Manufacturers
3.2.1 Global Iron Deficiency Anemia Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Iron Deficiency Anemia Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Iron Deficiency Anemia Treatment Revenue in 2021
3.3 Global Iron Deficiency Anemia Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Iron Deficiency Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Iron Deficiency Anemia Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Iron Deficiency Anemia Treatment Sales by Type
4.1.1 Global Iron Deficiency Anemia Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Iron Deficiency Anemia Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
4.2 Global Iron Deficiency Anemia Treatment Revenue by Type
4.2.1 Global Iron Deficiency Anemia Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Iron Deficiency Anemia Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Iron Deficiency Anemia Treatment Price by Type
4.3.1 Global Iron Deficiency Anemia Treatment Price by Type (2017-2022)
4.3.2 Global Iron Deficiency Anemia Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Iron Deficiency Anemia Treatment Sales by Application
5.1.1 Global Iron Deficiency Anemia Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Iron Deficiency Anemia Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
5.2 Global Iron Deficiency Anemia Treatment Revenue by Application
5.2.1 Global Iron Deficiency Anemia Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Iron Deficiency Anemia Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Iron Deficiency Anemia Treatment Price by Application
5.3.1 Global Iron Deficiency Anemia Treatment Price by Application (2017-2022)
5.3.2 Global Iron Deficiency Anemia Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Iron Deficiency Anemia Treatment Market Size by Type
6.1.1 North America Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
6.1.2 North America Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
6.2 North America Iron Deficiency Anemia Treatment Market Size by Application
6.2.1 North America Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
6.2.2 North America Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
6.3 North America Iron Deficiency Anemia Treatment Market Size by Country
6.3.1 North America Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
6.3.2 North America Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Iron Deficiency Anemia Treatment Market Size by Type
7.1.1 Europe Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
7.1.2 Europe Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
7.2 Europe Iron Deficiency Anemia Treatment Market Size by Application
7.2.1 Europe Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
7.2.2 Europe Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
7.3 Europe Iron Deficiency Anemia Treatment Market Size by Country
7.3.1 Europe Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
7.3.2 Europe Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Iron Deficiency Anemia Treatment Market Size by Type
8.1.1 Asia Pacific Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Iron Deficiency Anemia Treatment Market Size by Application
8.2.1 Asia Pacific Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Iron Deficiency Anemia Treatment Market Size by Region
8.3.1 Asia Pacific Iron Deficiency Anemia Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Iron Deficiency Anemia Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Iron Deficiency Anemia Treatment Market Size by Type
9.1.1 Latin America Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
9.1.2 Latin America Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
9.2 Latin America Iron Deficiency Anemia Treatment Market Size by Application
9.2.1 Latin America Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
9.2.2 Latin America Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
9.3 Latin America Iron Deficiency Anemia Treatment Market Size by Country
9.3.1 Latin America Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
9.3.2 Latin America Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Iron Deficiency Anemia Treatment Market Size by Type
10.1.1 Middle East and Africa Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Iron Deficiency Anemia Treatment Market Size by Application
10.2.1 Middle East and Africa Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Iron Deficiency Anemia Treatment Market Size by Country
10.3.1 Middle East and Africa Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AdvaCare Pharma
11.1.1 AdvaCare Pharma Corporation Information
11.1.2 AdvaCare Pharma Overview
11.1.3 AdvaCare Pharma Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AdvaCare Pharma Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AdvaCare Pharma Recent Developments
11.2 Akorn
11.2.1 Akorn Corporation Information
11.2.2 Akorn Overview
11.2.3 Akorn Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Akorn Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Akorn Recent Developments
11.3 Sun Pharmaceutical Industries Ltd.
11.3.1 Sun Pharmaceutical Industries Ltd. Corporation Information
11.3.2 Sun Pharmaceutical Industries Ltd. Overview
11.3.3 Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments
11.4 Akebia Therapeutics, Inc.
11.4.1 Akebia Therapeutics, Inc. Corporation Information
11.4.2 Akebia Therapeutics, Inc. Overview
11.4.3 Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Akebia Therapeutics, Inc. Recent Developments
11.5 Rockwell Medical, Inc.
11.5.1 Rockwell Medical, Inc. Corporation Information
11.5.2 Rockwell Medical, Inc. Overview
11.5.3 Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rockwell Medical, Inc. Recent Developments
11.6 Vifor Pharma Management Ltd.
11.6.1 Vifor Pharma Management Ltd. Corporation Information
11.6.2 Vifor Pharma Management Ltd. Overview
11.6.3 Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Vifor Pharma Management Ltd. Recent Developments
11.7 Shield Therapeutics
11.7.1 Shield Therapeutics Corporation Information
11.7.2 Shield Therapeutics Overview
11.7.3 Shield Therapeutics Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shield Therapeutics Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shield Therapeutics Recent Developments
11.8 AMAG Pharmaceuticals
11.8.1 AMAG Pharmaceuticals Corporation Information
11.8.2 AMAG Pharmaceuticals Overview
11.8.3 AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AMAG Pharmaceuticals Recent Developments
11.9 Pharmacosmos A/S
11.9.1 Pharmacosmos A/S Corporation Information
11.9.2 Pharmacosmos A/S Overview
11.9.3 Pharmacosmos A/S Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pharmacosmos A/S Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pharmacosmos A/S Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Iron Deficiency Anemia Treatment Industry Chain Analysis
12.2 Iron Deficiency Anemia Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Iron Deficiency Anemia Treatment Production Mode & Process
12.4 Iron Deficiency Anemia Treatment Sales and Marketing
12.4.1 Iron Deficiency Anemia Treatment Sales Channels
12.4.2 Iron Deficiency Anemia Treatment Distributors
12.5 Iron Deficiency Anemia Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Iron Deficiency Anemia Treatment Industry Trends
13.2 Iron Deficiency Anemia Treatment Market Drivers
13.3 Iron Deficiency Anemia Treatment Market Challenges
13.4 Iron Deficiency Anemia Treatment Market Restraints
14 Key Findings in The Global Iron Deficiency Anemia Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Iron Deficiency Anemia Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Ferrous Sulfate
Table 3. Major Manufacturers of Ferrous Gluconate
Table 4. Major Manufacturers of Ferrous Fumerate
Table 5. Major Manufacturers of Ferric Hydroxide
Table 6. Major Manufacturers of Sodium Ferric Gluconate
Table 7. Major Manufacturers of Iron Carbohydrates
Table 8. Major Manufacturers of Others
Table 9. Global Iron Deficiency Anemia Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Iron Deficiency Anemia Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Iron Deficiency Anemia Treatment Sales by Region (2017-2022) & (K Units)
Table 12. Global Iron Deficiency Anemia Treatment Sales Market Share by Region (2017-2022)
Table 13. Global Iron Deficiency Anemia Treatment Sales by Region (2023-2028) & (K Units)
Table 14. Global Iron Deficiency Anemia Treatment Sales Market Share by Region (2023-2028)
Table 15. Global Iron Deficiency Anemia Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Iron Deficiency Anemia Treatment Revenue Market Share by Region (2017-2022)
Table 17. Global Iron Deficiency Anemia Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Iron Deficiency Anemia Treatment Revenue Market Share by Region (2023-2028)
Table 19. Global Iron Deficiency Anemia Treatment Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Iron Deficiency Anemia Treatment Sales Share by Manufacturers (2017-2022)
Table 21. Global Iron Deficiency Anemia Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Iron Deficiency Anemia Treatment Revenue Share by Manufacturers (2017-2022)
Table 23. Iron Deficiency Anemia Treatment Price by Manufacturers (2017-2022) &(US$/Unit)
Table 24. Global Iron Deficiency Anemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Iron Deficiency Anemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iron Deficiency Anemia Treatment as of 2021)
Table 26. Iron Deficiency Anemia Treatment Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Iron Deficiency Anemia Treatment Product Offered
Table 28. Date of Manufacturers Enter into Iron Deficiency Anemia Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Iron Deficiency Anemia Treatment Sales by Type (2017-2022) & (K Units)
Table 31. Global Iron Deficiency Anemia Treatment Sales by Type (2023-2028) & (K Units)
Table 32. Global Iron Deficiency Anemia Treatment Sales Share by Type (2017-2022)
Table 33. Global Iron Deficiency Anemia Treatment Sales Share by Type (2023-2028)
Table 34. Global Iron Deficiency Anemia Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Iron Deficiency Anemia Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Iron Deficiency Anemia Treatment Revenue Share by Type (2017-2022)
Table 37. Global Iron Deficiency Anemia Treatment Revenue Share by Type (2023-2028)
Table 38. Iron Deficiency Anemia Treatment Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Iron Deficiency Anemia Treatment Price Forecast by Type (2023-2028) & (US$/Unit)
Table 40. Global Iron Deficiency Anemia Treatment Sales by Application (2017-2022) & (K Units)
Table 41. Global Iron Deficiency Anemia Treatment Sales by Application (2023-2028) & (K Units)
Table 42. Global Iron Deficiency Anemia Treatment Sales Share by Application (2017-2022)
Table 43. Global Iron Deficiency Anemia Treatment Sales Share by Application (2023-2028)
Table 44. Global Iron Deficiency Anemia Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Iron Deficiency Anemia Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Iron Deficiency Anemia Treatment Revenue Share by Application (2017-2022)
Table 47. Global Iron Deficiency Anemia Treatment Revenue Share by Application (2023-2028)
Table 48. Iron Deficiency Anemia Treatment Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Iron Deficiency Anemia Treatment Price Forecast by Application (2023-2028) & (US$/Unit)
Table 50. North America Iron Deficiency Anemia Treatment Sales by Type (2017-2022) & (K Units)
Table 51. North America Iron Deficiency Anemia Treatment Sales by Type (2023-2028) & (K Units)
Table 52. North America Iron Deficiency Anemia Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Iron Deficiency Anemia Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Iron Deficiency Anemia Treatment Sales by Application (2017-2022) & (K Units)
Table 55. North America Iron Deficiency Anemia Treatment Sales by Application (2023-2028) & (K Units)
Table 56. North America Iron Deficiency Anemia Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Iron Deficiency Anemia Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Iron Deficiency Anemia Treatment Sales by Country (2017-2022) & (K Units)
Table 59. North America Iron Deficiency Anemia Treatment Sales by Country (2023-2028) & (K Units)
Table 60. North America Iron Deficiency Anemia Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Iron Deficiency Anemia Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Iron Deficiency Anemia Treatment Sales by Type (2017-2022) & (K Units)
Table 63. Europe Iron Deficiency Anemia Treatment Sales by Type (2023-2028) & (K Units)
Table 64. Europe Iron Deficiency Anemia Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Iron Deficiency Anemia Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Iron Deficiency Anemia Treatment Sales by Application (2017-2022) & (K Units)
Table 67. Europe Iron Deficiency Anemia Treatment Sales by Application (2023-2028) & (K Units)
Table 68. Europe Iron Deficiency Anemia Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Iron Deficiency Anemia Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Iron Deficiency Anemia Treatment Sales by Country (2017-2022) & (K Units)
Table 71. Europe Iron Deficiency Anemia Treatment Sales by Country (2023-2028) & (K Units)
Table 72. Europe Iron Deficiency Anemia Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Iron Deficiency Anemia Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Iron Deficiency Anemia Treatment Sales by Type (2017-2022) & (K Units)
Table 75. Asia Pacific Iron Deficiency Anemia Treatment Sales by Type (2023-2028) & (K Units)
Table 76. Asia Pacific Iron Deficiency Anemia Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Iron Deficiency Anemia Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Iron Deficiency Anemia Treatment Sales by Application (2017-2022) & (K Units)
Table 79. Asia Pacific Iron Deficiency Anemia Treatment Sales by Application (2023-2028) & (K Units)
Table 80. Asia Pacific Iron Deficiency Anemia Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Iron Deficiency Anemia Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Iron Deficiency Anemia Treatment Sales by Region (2017-2022) & (K Units)
Table 83. Asia Pacific Iron Deficiency Anemia Treatment Sales by Region (2023-2028) & (K Units)
Table 84. Asia Pacific Iron Deficiency Anemia Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Iron Deficiency Anemia Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Iron Deficiency Anemia Treatment Sales by Type (2017-2022) & (K Units)
Table 87. Latin America Iron Deficiency Anemia Treatment Sales by Type (2023-2028) & (K Units)
Table 88. Latin America Iron Deficiency Anemia Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Iron Deficiency Anemia Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Iron Deficiency Anemia Treatment Sales by Application (2017-2022) & (K Units)
Table 91. Latin America Iron Deficiency Anemia Treatment Sales by Application (2023-2028) & (K Units)
Table 92. Latin America Iron Deficiency Anemia Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Iron Deficiency Anemia Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Iron Deficiency Anemia Treatment Sales by Country (2017-2022) & (K Units)
Table 95. Latin America Iron Deficiency Anemia Treatment Sales by Country (2023-2028) & (K Units)
Table 96. Latin America Iron Deficiency Anemia Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Iron Deficiency Anemia Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Iron Deficiency Anemia Treatment Sales by Type (2017-2022) & (K Units)
Table 99. Middle East and Africa Iron Deficiency Anemia Treatment Sales by Type (2023-2028) & (K Units)
Table 100. Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Iron Deficiency Anemia Treatment Sales by Application (2017-2022) & (K Units)
Table 103. Middle East and Africa Iron Deficiency Anemia Treatment Sales by Application (2023-2028) & (K Units)
Table 104. Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Iron Deficiency Anemia Treatment Sales by Country (2017-2022) & (K Units)
Table 107. Middle East and Africa Iron Deficiency Anemia Treatment Sales by Country (2023-2028) & (K Units)
Table 108. Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 110. AdvaCare Pharma Corporation Information
Table 111. AdvaCare Pharma Description and Major Businesses
Table 112. AdvaCare Pharma Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. AdvaCare Pharma Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. AdvaCare Pharma Recent Developments
Table 115. Akorn Corporation Information
Table 116. Akorn Description and Major Businesses
Table 117. Akorn Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Akorn Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Akorn Recent Developments
Table 120. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 121. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 122. Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 125. Akebia Therapeutics, Inc. Corporation Information
Table 126. Akebia Therapeutics, Inc. Description and Major Businesses
Table 127. Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Akebia Therapeutics, Inc. Recent Developments
Table 130. Rockwell Medical, Inc. Corporation Information
Table 131. Rockwell Medical, Inc. Description and Major Businesses
Table 132. Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Rockwell Medical, Inc. Recent Developments
Table 135. Vifor Pharma Management Ltd. Corporation Information
Table 136. Vifor Pharma Management Ltd. Description and Major Businesses
Table 137. Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Vifor Pharma Management Ltd. Recent Developments
Table 140. Shield Therapeutics Corporation Information
Table 141. Shield Therapeutics Description and Major Businesses
Table 142. Shield Therapeutics Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Shield Therapeutics Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Shield Therapeutics Recent Developments
Table 145. AMAG Pharmaceuticals Corporation Information
Table 146. AMAG Pharmaceuticals Description and Major Businesses
Table 147. AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. AMAG Pharmaceuticals Recent Developments
Table 150. Pharmacosmos A/S Corporation Information
Table 151. Pharmacosmos A/S Description and Major Businesses
Table 152. Pharmacosmos A/S Iron Deficiency Anemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Pharmacosmos A/S Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Pharmacosmos A/S Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Iron Deficiency Anemia Treatment Distributors List
Table 158. Iron Deficiency Anemia Treatment Customers List
Table 159. Iron Deficiency Anemia Treatment Market Trends
Table 160. Iron Deficiency Anemia Treatment Market Drivers
Table 161. Iron Deficiency Anemia Treatment Market Challenges
Table 162. Iron Deficiency Anemia Treatment Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Iron Deficiency Anemia Treatment Product Picture
Figure 3. Global Iron Deficiency Anemia Treatment Market Share by Type in 2021 & 2028
Figure 3. Ferrous Sulfate Product Picture
Figure 4. Ferrous Gluconate Product Picture
Figure 5. Ferrous Fumerate Product Picture
Figure 6. Ferric Hydroxide Product Picture
Figure 7. Sodium Ferric Gluconate Product Picture
Figure 8. Iron Carbohydrates Product Picture
Figure 9. Others Product Picture
Figure 10. Global Iron Deficiency Anemia Treatment Market Share by Application in 2021 & 2028
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Iron Deficiency Anemia Treatment Report Years Considered
Figure 15. Global Iron Deficiency Anemia Treatment Sales 2017-2028 (K Units)
Figure 16. Global Iron Deficiency Anemia Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Iron Deficiency Anemia Treatment Revenue 2017-2028 (US$ Million)
Figure 18. Global Iron Deficiency Anemia Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Iron Deficiency Anemia Treatment Sales Market Share by Region (2017-2022)
Figure 20. Global Iron Deficiency Anemia Treatment Sales Market Share by Region (2023-2028)
Figure 21. North America Iron Deficiency Anemia Treatment Sales YoY (2017-2028) & (K Units)
Figure 22. North America Iron Deficiency Anemia Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Iron Deficiency Anemia Treatment Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Iron Deficiency Anemia Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Iron Deficiency Anemia Treatment Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Iron Deficiency Anemia Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Iron Deficiency Anemia Treatment Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Iron Deficiency Anemia Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Iron Deficiency Anemia Treatment Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Iron Deficiency Anemia Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Iron Deficiency Anemia Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Iron Deficiency Anemia Treatment in the World: Market Share by Iron Deficiency Anemia Treatment Revenue in 2021
Figure 33. Global Iron Deficiency Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
Figure 35. Global Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
Figure 36. Global Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
Figure 37. Global Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
Figure 38. North America Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
Figure 39. North America Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
Figure 40. North America Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
Figure 41. North America Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
Figure 42. North America Iron Deficiency Anemia Treatment Sales Share by Country (2017-2028)
Figure 43. North America Iron Deficiency Anemia Treatment Revenue Share by Country (2017-2028)
Figure 44. United States Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
Figure 47. Europe Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
Figure 48. Europe Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
Figure 49. Europe Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
Figure 50. Europe Iron Deficiency Anemia Treatment Sales Share by Country (2017-2028)
Figure 51. Europe Iron Deficiency Anemia Treatment Revenue Share by Country (2017-2028)
Figure 52. Germany Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 53. France Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Iron Deficiency Anemia Treatment Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Iron Deficiency Anemia Treatment Revenue Share by Region (2017-2028)
Figure 63. China Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 66. India Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 68. China Taiwan Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
Figure 73. Latin America Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
Figure 75. Latin America Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Iron Deficiency Anemia Treatment Sales Share by Country (2017-2028)
Figure 77. Latin America Iron Deficiency Anemia Treatment Revenue Share by Country (2017-2028)
Figure 78. Mexico Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Iron Deficiency Anemia Treatment Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Iron Deficiency Anemia Treatment Revenue Share by Country (2017-2028)
Figure 87. Turkey Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Iron Deficiency Anemia Treatment Revenue (2017-2028) & (US$ Million)
Figure 90. Iron Deficiency Anemia Treatment Value Chain
Figure 91. Iron Deficiency Anemia Treatment Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

以下、関連資料のご紹介

ファンコニ貧血治療のグローバル市場インサイト・予測（～2028年）

Global Fanconi Anemia Treatment Market Insights, Forecast to 2028
QY2207C3459 2022年7月11日 125Pages
新型コロナウイルス感染症のパンデミックにより、世界のファンコニ貧血治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にファンコニ貧血治療...

ライソゾーム酸性リパーゼ欠損症（LAL-D）治療の世界市場2022年-2030年

Lysosomal Acid Lipase Deficiency Treatment Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
SRT22JL0022 2022年6月 124Pages
Straits Researchの当調査資料は、世界のライソゾーム酸性リパーゼ欠損症（LAL-D）治療市場を調査対象とし、市場概要、主要企業、種類別分析、用途別分析、アジア太平洋市場、ヨーロッパ市場、北米市場、南米市場、中東・アフリカ市場などの多面的な分析結果をまとめております。当書に掲載されている...

世界の総鉄結合能（TIBC）試薬市場予測（～2028年）：R1 1 * 90 ml; R2 1 * 60 ml、R1 1 * 90 ml; R2 1 * 30 ml、R1 1 * 100 ml; R2 1 * 10 ml、R1 4 * 9 ml; R2 4 * 4 ml、その他

Global Total Iron-Binding Capacity (TIBC) Reagents Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8975 2022年5月 98Pages
総鉄結合能（TIBC）試薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供...

低プロトロンビン血症治療のグローバル市場インサイト・予測（～2028年）

Global Hypoprothrombinemia Treatment Market Insights, Forecast to 2028
QY2207E09235 2022年7月 129Pages
新型コロナウイルス感染症のパンデミックにより、世界の低プロトロンビン血症治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に低プロトロン...

結膜炎治療のグローバル市場インサイト・予測（～2028年）

Global Conjunctivitis Treatment Market Insights, Forecast to 2028
QY2207C3480 2022年7月11日 78Pages
新型コロナウイルス感染症のパンデミックにより、世界の結膜炎治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に結膜炎治療の世界市場のxx...

ファンコニ貧血治療のグローバル市場インサイト・予測（～2028年） Fanconi anemia is an autosomal recessive illness marked by impaired haemopoiesis, congenital anomalies, and a significant incidence of solid tumors and acute myeloid leukaemia in patients. It is a rare disease that affects the bone marrow and is handed down via families (inherited). Fanconi anemia i…
ライソゾーム酸性リパーゼ欠損症（LAL-D）治療の世界市場2022年-2030年 Summary: In this Lysosomal Acid Lipase Deficiency Treatment Market report, offers a comprehensive analysis of key market trends in the global Lysosomal Acid Lipase Deficiency Treatment market. It also includes discussion on historical trends, current market status, competitive landscape, growth oppo…
世界の総鉄結合能（TIBC）試薬市場予測（～2028年）：R1 1 * 90 ml; R2 1 * 60 ml、R1 1 * 90 ml; R2 1 * 30 ml、R1 1 *… The Total Iron-Binding Capacity (TIBC) Reagents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
コードレスヘアアイロンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Cordless Curling Iron Market Due to the COVID-19 pandemic, the global Cordless Curling Iron market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.…
合成硫化鉄のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Synthetic Iron Sulfide Market Due to the COVID-19 pandemic, the global Synthetic Iron Sulfide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-202…